Full Text View
Tabular View
No Study Results Posted
Related Studies
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
This study has been completed.
Study NCT00078494   Information provided by National Institutes of Health Clinical Center (CC)
First Received: February 27, 2004   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nasopharyngeal Neoplasms
Additional conditions recognized in this trial
Neoplasms
Recurrence
More general conditions related to this trial
Disease Attributes
Head and Neck Neoplasms
Nasopharyngeal Diseases
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pathologic Processes
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
EBV-LMP-2
Sponsors listed in this trial
National Institutes of Health Clinical Center (CC)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services